Independent resource / since the question matters
Bright Basin 55 is built for people who want a steadier way to examine what is known, unknown, and contested about ibogaine for substance use disorders.
Evidence before hype.
Why this exists
Tamarind Signal helps people examine what is known, unknown, and contested about ibogaine for substance use disorders. It foregrounds evidence limits, safety concerns, and regulatory realities alongside emerging research.
The aim is not to sell an outcome or direct anyone toward treatment. It is to offer a clearer starting point for people affected by substance use, families, researchers, and policymakers who need context before certainty.
Our main evidence overview provides the wider frame, while the site’s ways of using this resource explains how its topic areas are arranged for practical reading.
“When the stakes are high, uncertainty belongs in the conversation.”
Our editorial approach
We look to research literature, study registries, and official materials rather than treating promotional language as proof. The ClinicalTrials.gov study registry is one useful public record for checking whether a study has been registered and how it is described.
Small samples, follow-up gaps, selection effects, and incomplete reporting can change what a result means. We describe those limits rather than smoothing them away.
Questions involving policy, safety, and access are checked against primary official sources where possible, including the FDA’s drug safety information for public safety notices and related context.
We use plain language, distinguish observation from conclusion, and make room for disagreement where the record does not settle a question.
What we cover
Bright Basin 55 organizes material around evidence, risk, policy, and decision context. The focus is on helping readers locate the question they are asking and see what kind of support the available record can—and cannot—provide.
Readers comparing accounts of psychedelic drug ibogaine can use the same framework that informs our discussion of how ibogaine works: identify the claim, look for the source, and separate a proposed explanation from an established conclusion.
Where people encounter treatment-oriented language online, we place it in context rather than ranking providers. That includes questions often raised around treatment centers in Canada, treatment in Mexico, and treatment in the United States.
Who this is for
This resource is for people affected by substance use, family members, researchers, and policymakers who want a candid account of what can be checked. It is also for readers trying to understand why online descriptions can diverge so sharply.
Some visitors arrive through discussions of ibogaine for alcohol addiction or accounts of extreme alcoholism. Others are weighing descriptions of ibogaine HCl or comparisons between ibogaine and mushrooms. These are different entry points, not reasons to skip careful source checking.
Costs and destination-based claims also need scrutiny. Information about the cost of ibogaine treatment in Mexico, ibogaine retreats in Mexico, or a purported best ibogaine treatment clinic should not be mistaken for independent confirmation of quality, safety, or suitability.
Independent by design
Bright Basin 55 is an independent information resource. It is not a clinic, medical provider, licensed treatment center, or legal authority, and it does not provide medical or legal advice. Its purpose is to make careful reading easier—not to replace professional judgment or individual care.
See the evidence review